First case report on Professor Scolyer’s experimental immunotherapy, 10 months in
The first preprint report provides a detailed summary of treatment outcomes so far.
Clinical details of Professor Richard Scolyer’s experimental glioblastoma therapy have been published for the first time, showing clear evidence that combination immunotherapy can cross the blood–brain/tumour barrier.
The 2024 Australian of the Year has publicly shared regular updates about his progress since the shock diagnosis almost a year ago.
